Medicare Enrolled
Dr. Shruti Sharma
Student in an Organized Health Care Education/Training Program · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharma
Dr. Shruti Sharma is a student in an organized health care education/training program in San Antonio, TX, with 9 years in practice. Based on federal Medicare data, Dr. Sharma performed 61,683 Medicare services across 3,154 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $3,199 from 33 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice▲ Top 0% volume in TX$ $3,199 industry payments
Medicare Practice Summary
Medicare Utilization ↗61,683
Medicare services
Top 0% in TX for student in an organized health care education/training program
3,154
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,854 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 10,200 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 9,150 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 8,895 | $2 | $20 |
| Paclitaxel chemotherapy injection | 8,262 | $0 | $8 |
| Iron sucrose injection (Venofer) | 5,200 | $0 | $2 |
| Azacitidine chemotherapy injection | 5,000 | $0 | $13 |
| Immune globulin infusion (Octagam) | 3,630 | $33 | $234 |
| Flow cytometry, additional marker | 1,033 | $18 | $180 |
| Contrast dye for imaging (iodine-based) | 1,002 | $0 | $3 |
| Dexamethasone injection (steroid) | 948 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 840 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 700 | $1 | $114 |
| Blood draw (venipuncture) | 543 | $8 | $20 |
| Complete blood count (CBC) with differential | 513 | $7 | $36 |
| Comprehensive metabolic blood panel | 456 | $10 | $64 |
| Immunoglobulin level test | 309 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 309 | $21 | $157 |
| Office visit, established patient (30-39 min) | 283 | $93 | $368 |
| Office visit, established patient (20-29 min) | 242 | $62 | $250 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 228 | $71 | $1,348 |
| Ferritin level test (iron stores) | 222 | $13 | $60 |
| Iron level test | 222 | $6 | $27 |
| Iron binding capacity test | 222 | $8 | $35 |
| Administration of chemotherapy into vein, 1 hour or less | 215 | $97 | $707 |
| Lactate dehydrogenase (enzyme) level | 211 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 197 | $15 | $100 |
| Injection, carboplatin, 50 mg | 192 | $2 | $300 |
| Injection of additional new drug or substance into vein | 176 | $11 | $108 |
| Injection, diphenhydramine hcl, up to 50 mg | 149 | $1 | $7 |
| Vitamin B-12 level test | 146 | $14 | $76 |
| Measurement of immunoglobulin light chains | 146 | $17 | $60 |
| Red blood count automated, with additional calculations | 146 | $5 | $26 |
| Folic acid level test | 145 | $14 | $73 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 121 | $46 | $313 |
| C-reactive protein test (inflammation marker) | 118 | $5 | $33 |
| Hospital follow-up visit, moderate complexity | 112 | $59 | $247 |
| Drug injection, under skin or into muscle | 93 | $10 | $96 |
| Sed rate test (inflammation marker) | 85 | $3 | $36 |
| Prothrombin time test (blood clotting) | 78 | $4 | $30 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 70 | $55 | $211 |
| Administration of additional new drug or substance into vein, 1 hour or less | 66 | $49 | $344 |
| Injection, zoledronic acid, 1 mg | 66 | $5 | $431 |
| Administration of chemotherapy into vein, each additional hour | 65 | $20 | $161 |
| Unclassified drugs | 59 | $1 | $8 |
| Office visit, established patient, complex (40-54 min) | 54 | $131 | $496 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 44 | $14 | $94 |
| Flow cytometry technique for dna or cell analysis, first marker | 43 | $53 | $298 |
| New patient office visit (45-59 min) | 43 | $114 | $565 |
| Haptoglobin (serum protein) level | 33 | $12 | $66 |
| Urinalysis with microscopic exam | 30 | $3 | $28 |
| Coagulation assessment blood test, plasma or whole blood | 30 | $6 | $52 |
| Coagulation function measurement, d-dimer; quantitative | 29 | $10 | $129 |
| Reticulated (young) platelet measurement | 28 | $34 | $143 |
| Beta-2 microglobulin (protein) level | 27 | $14 | $96 |
| Microscopic examination for white blood cells with manual cell count | 26 | $4 | $22 |
| Irrigation of implanted venous access drug delivery device | 26 | $17 | $114 |
| Complete blood count (CBC), automated | 25 | $6 | $34 |
| Thyroid stimulating hormone (TSH) test | 23 | $16 | $80 |
| Infusion, normal saline solution , 1000 cc | 21 | $2 | $19 |
| Drawing of blood for a medical problem | 20 | $69 | $264 |
| Initial hospital admission, moderate complexity | 20 | $100 | $470 |
| Application of on-body injector for under skin injection | 19 | $14 | $96 |
| Hospital follow-up visit, high complexity | 18 | $91 | $357 |
| New patient office visit (30-44 min) | 17 | $72 | $372 |
| Infusion into a vein for hydration, each additional hour | 16 | $10 | $75 |
| New patient office visit, complex (60-74 min) | 14 | $156 | $709 |
| Protein measurement, serum | 12 | $11 | $99 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.6% high complexity
66.9% medium
9.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,199
Total received (2020-2024)
Avg $640/year across 5 years
Top 11% in TX for student in an organized health care education/training program
33
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,936 (91.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$264 (8.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$900
2023$941
2022$836
2021$377
2020$145
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$354
Amgen Inc.
$295
AstraZeneca Pharmaceuticals LP
$265
Tempus AI, Inc
$194
Seagen Inc.
$185
Incyte Corporation
$138
Karyopharm Therapeutics Inc.
$135
Janssen Biotech, Inc.
$125
Genmab U.S., Inc.
$125
Bayer Healthcare Pharmaceuticals Inc.
$125
Novocure Inc.
$124
Rigel Pharmaceuticals, Inc.
$112
TELA Bio, Inc.
$100
Pharmacyclics LLC, An AbbVie Company
$100
BeiGene USA, Inc.
$100
Myriad Genetic Laboratories, Inc.
$88
GENZYME CORPORATION
$86
ADC Therapeutics America, Inc.
$84
ABBVIE INC.
$77
Lilly USA, LLC
$73
Merck Sharp & Dohme Corporation
$57
Abbott Laboratories
$45
Merck Sharp & Dohme LLC
$43
PFIZER INC.
$23
EUSA Pharma (US) LLC
$22
JAZZ PHARMACEUTICALS INC.
$21
Ipsen Biopharmaceuticals, Inc
$17
EISAI INC.
$16
Eisai Inc.
$15
Blueprint Medicines Corporation
$14
Astellas Pharma US Inc
$14
TerSera Therapeutics LLC
$13
AbbVie Inc.
$13
Top 3 companies account for 28.6% of total payments
Associated products mentioned in payments ›
AYVAKIT · BRUKINSA · CALQUENCE · ENHERTU · ERLEADA · Epkinly · IBRANCE · IMFINZI · Imbruvica · JAKAFI · KEYTRUDA · LUMAKRAS · Lenvima · MYRISK · Nubeqa · OPDIVO · OPDUALAG · OPTUNE LUA (NOVOTTF-200T) · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PADCEV · PEMAZYRE · PROCLAIM · RETEVMO · Rezlidhia · SARCLISA · SOMATULINE DEPOT · Sylvant · TAGRISSO · TIVDAK · TUKYSA · VENCLEXTA · Vectibix · XPOVIO · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Student in an Organized Health Care Education/Training Programs within 10 mi
2,334
Per 100K population
114.6
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharma is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 11%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sharma performed 10,200 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $3,199 from 33 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other student in an organized health care education/training programs in San Antonio?
Dr. Sharma's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student in an Organized Health Care Education/Training Programs in San Antonio
Browse student in an organized health care education/training programs in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Student in an Organized Health Care Education/Training Programs in TX
Student in an Organized Health Care Education/Training Programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student in an Organized Health Care Education/Training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology